The Tuberculin Skin Test (TST) represents a cornerstone in the detection and control of tuberculosis (TB) infection worldwide. Often referred to as the Mantoux test, this procedure evaluates an individual’s immune response to specific proteins derived from the TB bacterium. Proper execution and interpretation of Tuberculin Skin Test methods are paramount for identifying latent TB infection, preventing its progression to active disease, and safeguarding community health. This comprehensive guide will walk you through the essential steps and considerations for effectively utilizing the TST.
Understanding the Tuberculin Skin Test (TST)
The Tuberculin Skin Test is a diagnostic procedure designed to detect whether a person has been infected with Mycobacterium tuberculosis. It does not distinguish between latent TB infection (LTBI) and active TB disease, but rather indicates exposure and the presence of an immune response. The test involves injecting a small amount of purified protein derivative (PPD) tuberculin into the skin.
What is PPD Tuberculin?
PPD tuberculin is a sterile, filtered extract of cultures of Mycobacterium tuberculosis. When introduced into the skin of a person previously infected with TB bacteria, it can elicit a delayed-type hypersensitivity reaction. This reaction is a sign that the body’s immune system has encountered the TB pathogen before and has developed an immunological memory.
Purpose of the TST
The primary purpose of the Tuberculin Skin Test is to identify individuals with latent TB infection. These individuals carry the TB bacteria in their bodies but do not have active disease symptoms and cannot spread the infection to others. However, latent TB can progress to active TB disease, making early identification and treatment critical. Understanding these Tuberculin Skin Test methods is vital for clinicians.
Preparation and Administration of Tuberculin Skin Test Methods
Accurate administration is fundamental to reliable TST results. A standardized approach ensures consistency and minimizes errors in the Tuberculin Skin Test methods.
Choosing the Injection Site
The preferred site for the Tuberculin Skin Test is the volar (inner) surface of the forearm, about 2 to 4 inches below the elbow. This area is typically hairless, free of lesions, and has less pigmentation, making it easier to observe the reaction. It is crucial to avoid areas with veins, scars, or dermatitis, as these can interfere with accurate reading.
Materials Required
- Tuberculin Syringe: A 1-ml tuberculin syringe with a 26- or 27-gauge needle (1/4 to 1/2 inch long) is specifically designed for intradermal injections.
- PPD Tuberculin Solution: The standard dose is 0.1 ml of 5 tuberculin units (TU) of PPD.
- Alcohol Swab: For cleaning the injection site.
Injection Technique
The intradermal injection technique is critical for proper Tuberculin Skin Test methods. The goal is to deposit the PPD solution into the superficial layer of the skin, not subcutaneously or intramuscularly.
- Cleanse the Site: Swab the chosen site with an alcohol wipe and allow it to air dry completely.
- Position the Patient: Have the patient sit comfortably with their arm supported, palm facing upward.
- Stretch the Skin: Hold the forearm firmly, stretching the skin taut between your thumb and forefinger.
- Insert the Needle: Insert the needle, bevel up, into the top layer of the skin at an angle of 5 to 15 degrees. The needle should be almost parallel to the skin surface.
- Inject the PPD: Slowly inject the 0.1 ml of PPD. A distinct, pale wheal (a raised blister-like bump), 6 to 10 mm in diameter, should form at the injection site. This wheal, sometimes called a bleb, indicates a successful intradermal injection.
- Withdraw the Needle: Withdraw the needle smoothly. Do not massage or cover the injection site with a bandage, as this can affect the test results.
Instruct the patient not to scratch, rub, or apply creams to the site until the test is read.
Reading and Interpretation of Tuberculin Skin Test Results
The accurate reading of the Tuberculin Skin Test is as crucial as its administration. Misinterpretation can lead to unnecessary treatment or missed diagnoses. These Tuberculin Skin Test methods require careful attention to detail.
Timing of the Reading
The TST should be read by a trained healthcare professional 48 to 72 hours after the injection. Reading the test too early or too late can lead to inaccurate results. The delayed-type hypersensitivity reaction takes time to develop fully.
What to Measure: Induration, Not Redness
When reading the TST, the healthcare professional must feel for and measure the diameter of the induration (a firm, raised, hardened area) across the forearm, perpendicular to the long axis. Redness (erythema) alone, without induration, is not considered a positive reaction and should not be measured.
Measurement Technique
- Palpate the Site: Gently feel the injection site to locate the borders of the induration.
- Mark the Edges: Use a pen to make a mark at the widest points of the induration.
- Measure the Diameter: Use a ruler to measure the diameter of the induration in millimeters (mm). Record the measurement accurately.
Interpretation Criteria
The interpretation of TST results varies based on the individual’s risk factors for TB infection and progression to disease. There are generally three thresholds for a positive reaction:
- ≥ 5 mm Induration is considered positive for:
- People living with HIV.
- Recent contacts of individuals with active TB disease.
- Organ transplant recipients and other immunosuppressed patients (e.g., those on prolonged corticosteroid therapy, TNF-α antagonists).
- Individuals with fibrotic changes on chest X-ray consistent with prior TB disease.
- Recent immigrants (within 5 years) from high-prevalence countries.
- Injection drug users.
- Residents and employees of high-risk congregate settings (e.g., prisons, nursing homes, hospitals, homeless shelters).
- Mycobacteriology laboratory personnel.
- Children under 5 years of age.
- Infants, children, and adolescents exposed to adults in high-risk categories.
- People with certain medical conditions that increase the risk of TB (e.g., diabetes, silicosis, end-stage renal disease, weight loss, gastrectomy).
- People with no known risk factors for TB.
A negative TST result means an induration of 0 mm or smaller than the respective positive threshold. However, a negative result does not definitively rule out TB infection, especially in immunocompromised individuals.
Factors Affecting TST Results
Several factors can influence the accuracy of Tuberculin Skin Test methods, leading to false-positive or false-negative results.
False-Positive Results
- BCG Vaccination: Individuals who have received the Bacillus Calmette-Guérin (BCG) vaccine, often given in countries with high TB prevalence, may have a positive TST reaction. The reaction usually wanes over time.
- Infection with Non-Tuberculous Mycobacteria (NTM): Exposure to other types of mycobacteria found in the environment can sometimes trigger a positive TST.
- Incorrect Administration or Reading: Errors in technique can lead to misinterpretation.
False-Negative Results
- Recent TB Infection: It takes 2-8 weeks after infection for the immune system to react to PPD (window period).
- Weakened Immune System: Immunosuppression due to HIV, certain medications (e.g., corticosteroids), or other medical conditions can suppress the immune response, leading to an anergic (no reaction) or falsely negative TST.
- Very Young Age: Infants and very young children may have immature immune systems.
- Overwhelming Active TB Disease: In severe cases, the immune system may be too overwhelmed to mount a reaction.
- Live-Virus Vaccinations: Recent vaccination with live viruses (e.g., measles, mumps, rubella, varicella) can temporarily suppress TST reactivity.
Comparison with Other TB Tests
While Tuberculin Skin Test methods are widely used, Interferon-Gamma Release Assays (IGRAs) are another important diagnostic tool for TB infection. IGRAs, such as the QuantiFERON-TB Gold Plus (QFT-Plus) and T-SPOT.TB, are blood tests that measure a person’s immune response to TB-specific antigens. They are not affected by prior BCG vaccination and may be preferred in certain populations.
Advantages of TST
- Inexpensive and widely available.
- Requires minimal laboratory infrastructure.
Limitations of TST
- Requires a follow-up visit for reading.
- Subject to reader bias.
- Can be affected by BCG vaccination and NTM exposure.
Importance of Follow-Up
Regardless of the Tuberculin Skin Test results, appropriate follow-up is crucial. A positive TST indicates TB infection and warrants further evaluation, typically including a chest X-ray and symptom assessment, to rule out active TB disease. If active TB is excluded, treatment for latent TB infection may be recommended to prevent future progression to active disease. A negative TST, especially in high-risk individuals or those with symptoms, may still require clinical judgment and potentially further testing or re-evaluation.
Conclusion
Tuberculin Skin Test methods remain an indispensable tool in the fight against tuberculosis. From meticulous administration to precise interpretation, each step in the TST process is vital for accurate diagnosis of TB infection. Understanding the nuances of PPD injection, induration measurement, and risk-factor-based interpretation empowers healthcare professionals to make informed decisions. If you have concerns about TB exposure or require a Tuberculin Skin Test, consult with a qualified healthcare provider to ensure proper screening and appropriate management.